Literature DB >> 19153324

Risk factors and management of ascites after liver resection to treat hepatocellular carcinoma.

Takeaki Ishizawa1, Kiyoshi Hasegawa, Norihiro Kokudo, Keiji Sano, Hiroshi Imamura, Yoshifumi Beck, Yasuhiko Sugawara, Masatoshi Makuuchi.   

Abstract

OBJECTIVES: To identify risk factors for a massive amount of ascites after liver resection to treat hepatocellular carcinoma and to evaluate our postoperative management strategy.
DESIGN: Case-control study.
SETTING: University hospital. PATIENTS: Two hundred three patients who underwent liver resection to treat hepatocellular carcinoma between January 1, 2003, and December 31, 2004. MAIN OUTCOME MEASURES: Presence or absence of a large number of ascites (LA), defined as postoperative daily ascitic fluid drainage exceeding 10 mL per kilogram of body weight, and operative morbidity, mortality, and treatment costs.
RESULTS: A large number of ascites developed in 31 patients (15%). Multivariate analysis revealed that blood loss greater than 1000 mL (relative risk, 6.38; 95% confidence interval, 2.19-20.7; P = .001) and preoperative platelet count less than 100 x 10(3)/microL (4.75; 1.75-13.1; P = .002) independently increased the risk of LA. In patients with LA, urinary output on postoperative days 1 to 3 was significantly lower than in patients without LA, and daily ascitic fluid volume tended to peak on postoperative day 7. No operative mortality was related to liver failure; however, patients with LA required a larger volume of fresh frozen plasma than those without LA (median [range], 1600 [0-16 800] mL vs 480 [0-5760] mL; P < .001), resulting in higher hospital costs.
CONCLUSIONS: Large blood loss and low platelet count were independent risk factors for LA. Although it was possible to safely manage postoperative ascites using routine administration of diuretic agents and fresh frozen plasma, step-by-step trials are required to reduce the need for transfusion of fresh frozen plasma.

Entities:  

Mesh:

Year:  2009        PMID: 19153324     DOI: 10.1001/archsurg.2008.511

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  58 in total

1.  Laparoscopic liver resections for hepatocellular carcinoma. Can we extend the surgical indication in cirrhotic patients?

Authors:  Federica Cipriani; Corrado Fantini; Francesca Ratti; Roberto Lauro; Hadrien Tranchart; Mark Halls; Vincenzo Scuderi; Leonid Barkhatov; Bjorn Edwin; Roberto I Troisi; Ibrahim Dagher; Paolo Reggiani; Giulio Belli; Luca Aldrighetti; Mohammad Abu Hilal
Journal:  Surg Endosc       Date:  2017-07-17       Impact factor: 4.584

2.  Using a 'no drain' policy in 342 laparoscopic hepatectomies: which factors predict failure?

Authors:  Takeaki Ishizawa; Noah B Zuker; Claudius Conrad; Hao-Jan Lei; Oriana Ciacio; Norihiro Kokudo; Brice Gayet
Journal:  HPB (Oxford)       Date:  2013-08-29       Impact factor: 3.647

3.  Is it a time to modify the BCLC guidelines in terms of the role of surgery?

Authors:  Norihiro Kokudo
Journal:  World J Surg       Date:  2015-02       Impact factor: 3.352

4.  3D visualization reduces operating time when compared to high-definition 2D in laparoscopic liver resection: a case-matched study.

Authors:  Vimalraj Velayutham; David Fuks; Takeo Nomi; Yoshikuni Kawaguchi; Brice Gayet
Journal:  Surg Endosc       Date:  2015-03-25       Impact factor: 4.584

5.  Impact of intraoperative blood loss on the short-term outcomes of laparoscopic liver resection.

Authors:  Rahul Gupta; David Fuks; Christophe Bourdeaux; Pejman Radkani; Takeo Nomi; Christian Lamer; Brice Gayet
Journal:  Surg Endosc       Date:  2017-03-31       Impact factor: 4.584

6.  Potential role of cholinesterases to predict short-term outcome after hepatic resection for hepatocellular carcinoma.

Authors:  Matteo Donadon; Matteo Cimino; Fabio Procopio; Emanuela Morenghi; Marco Montorsi; Guido Torzilli
Journal:  Updates Surg       Date:  2012-08-22

7.  After laparoscopic liver resection for colorectal liver metastases, age does not influence morbi-mortality.

Authors:  Alban Zarzavadjian Le Bian; Nicolas Tabchouri; Mostefa Bennamoun; Christophe Louvet; Candice Tubbax; Anthony Sarran; Marine Lefevre; Marc Beaussier; Frédéric Pamoukdjian; Philippe Wind; Brice Gayet; David Fuks
Journal:  Surg Endosc       Date:  2019-01-22       Impact factor: 4.584

8.  Short- and Long-Term Outcomes of Liver Resection for Intrahepatic Cholangiocarcinoma Associated with the Metabolic Syndrome.

Authors:  Christian Hobeika; François Cauchy; Nicolas Poté; Pierre-Emmanuel Rautou; François Durand; Olivier Farges; Safi Dokmak; Valérie Vilgrain; Maxime Ronot; Valérie Paradis; Olivier Soubrane
Journal:  World J Surg       Date:  2019-08       Impact factor: 3.352

9.  Incidence, risk factors and consequences of bile leakage following laparoscopic major hepatectomy.

Authors:  François Cauchy; David Fuks; Takeo Nomi; Lilian Schwarz; Ajay Belgaumkar; Olivier Scatton; Olivier Soubrane; Brice Gayet
Journal:  Surg Endosc       Date:  2015-11-17       Impact factor: 4.584

Review 10.  Management of small hepatocellular carcinoma in cirrhosis: focus on portal hypertension.

Authors:  Virginia Hernandez-Gea; Fanny Turon; Annalisa Berzigotti; Augusto Villanueva
Journal:  World J Gastroenterol       Date:  2013-02-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.